| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.508 | 32.141 | - | - | - | 31.654 | 37.677 | 43.279 | 48.365 | 52.144 |
| Total Income - EUR | 10.508 | 32.141 | - | - | - | 38.890 | 37.677 | 43.279 | 48.365 | 52.566 |
| Total Expenses - EUR | 10.628 | 28.361 | - | - | - | 51.761 | 38.343 | 51.052 | 48.361 | 58.705 |
| Gross Profit/Loss - EUR | -120 | 3.780 | - | - | - | -12.872 | -666 | -7.773 | 3 | -6.139 |
| Net Profit/Loss - EUR | -435 | 2.816 | - | - | - | -14.038 | -1.796 | -9.071 | 3 | -6.139 |
| Employees | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Genes Tim Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 101 | 57 | - | - | - | 2 | 2 | 2 | 2 | 2 |
| Current Assets | 1.869 | 7.734 | - | - | - | 5.570 | 8.359 | 1.533 | 4.301 | 7.841 |
| Inventories | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | 153 | 3.940 | - | - | - | 5.552 | 5.428 | 1.455 | 2.285 | 3.543 |
| Cash | 1.716 | 3.794 | - | - | - | 18 | 2.931 | 78 | 2.016 | 4.298 |
| Shareholders Funds | -390 | 2.430 | - | - | - | -38.500 | -39.442 | -48.636 | -48.486 | -54.354 |
| Social Capital | 45 | 45 | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.361 | 5.362 | - | - | - | 44.072 | 47.803 | 50.171 | 52.789 | 62.197 |
| Income in Advance | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Genes Tim Med Srl